English
Back
Download
Log in to access Online Inquiry
Back to the Top

Despite recent share price drops, Gansu Longshenrongfa Pharm...

Despite recent share price drops, Gansu Longshenrongfa Pharmaceutical's P/E is still higher than most firms. If medium-term earnings trends persist, shareholders' investments could be at risk and potential investors may pay an excessive premium.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
1001 Views
Comment
Sign in to post a comment